Alando J. Ballantyne Distinguished Chair of Head and Neck Surgery/ Medical Director
Otolaryngology (ENT)
Dr. Gary L. Clayman, MD
|
|
Give Review
Doctor Gary L. Clayman, MD is an expert in the field of Otolaryngology (ENT). He studied medicine at Northeast Ohio Medical University. He received awards:"America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer", "Fellow (FAAO-HNS)", "Fellow (FACS)" and "Super Doctor". Gary L. Clayman, MD is a published doctor. He has 76 publications published. The most current publication "Development and Characterization of Six New Human Papillary Thyroid Carcinoma Cell Lines." He accepts Medicare.
Publications
- Development and Characterization of Six New Human Papillary Thyroid Carcinoma Cell Lines.
- Mutational landscape of aggressive cutaneous squamous cell carcinoma.
- Well differentiated thyroid Cancer with aerodigestive tract invasion: Long-term control and functional outcomes.
- Use of transOral sonography with an endocavitary transducer in diagnosis, fine-needle aspiration biopsy, and intraoperative localization of retropharyngeal masses.
- Measuring the Extent of Total Thyroidectomy for Differentiated Thyroid Carcinoma Using Radioactive Iodine Imaging: Relationship With Serum Thyroglobulin and Clinical O...
- Src inhibitors in suppression of papillary thyroid carcinoma growth.
- Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy.
- Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.
- Assembly And Initial Characterization Of A Panel Of 85 Genomically Validated Cell Lines From Diverse Head And Neck Tumor Sites.
- Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas.
- Long-term outcomes of microsurgical reconstruction for large tracheal defects.
- Preoperative lateral neck ultrasonography as a long-term outcome predictor in papillary thyroid Cancer.
- Phosphoproteomic analysis of signaling pathways in Head and neck squamous cell carcinoma patient samples.
- New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI.
- MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo.
- Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thy...
- Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck Cancer but not tumor characteristics.
- Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.
- Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma.
- Postoperative external beam radiotherapy for differentiated thyroid Cancer: outcomes and morbidity with conformal treatment.
- Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma.
- Aurora kinase A inhibition and paclitaxel as targeted combination therapy for Head and neck squamous cell carcinoma.
- The successful use of sorafenib to treat pediatric papillary thyroid carcinoma.
- Inhibition of the growth of papillary thyroid carcinoma cells by CI-1040.
- Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid Cancer.
- High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma.
- Predictors of level V metastasis in well-differentiated thyroid Cancer.
- Small molecule c-MET inhibitor PHA665752: effect on cell growth and motility in papillary thyroid carcinoma.
- Surgical management of recurrent thyroid Cancer.
- Sorafenib potently inhibits papillary thyroid carcinomas harboring RET/PTC1 rearrangement.
- Postoperative radiotherapy for advanced medullary thyroid Cancer--local disease control in the modern era.
- Correlation between SPINK5 gene mutations and clinical manifestations in Netherton Syndrome patients.
- Recent advances in thyroid Cancer.
- Recent advances in thyroid Cancer. In brief.
- An orthotopic model of papillary thyroid carcinoma in athymic nude mice.
- LBP-1b, LBP-9, and LBP-32/MGR detected in syncytiotrophoblasts from first-trimester human placental tissue and their transcriptional regulation.
- Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification.
- Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin Cancer and tumor progression.
- Differential responses of human papillary thyroid Cancer cell lines carrying the RET/PTC1 rearrangement or a BRAF mutation to MEK1/2 inhibitors.
- Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma.
- Transoral resection of thyroid Cancer metastasis to lateral retropharyngeal nodes.
- A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation.
- Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma.
- 4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of nonmelanoma skin Cancer: a case-control analysis.
- Elevated human tissue kallikrein levels in the stratum corneum and serum of peeling skin Syndrome-type B patients suggests an over-desquamation of corneocytes.
- Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell Cancer of the head and neck.
- Serine protease activity and residual LEKTI expression determine phenotype in Netherton Syndrome.
- Fenretinide activity in retinoid-resistant oral Leukoplakia.
- Stent fabrication for graft immobilization following wide surgical excision of myofibroblastic sarcoma of the buccal mucosa: a clinical report.
- In vitro sensitivity to ultraviolet B light and skin Cancer risk: a case-control analysis.
- Headpin: a serpin with endogenous and exogenous suppression of angiogenesis.
- Lymph node metastases from cutaneous squamous cell carcinoma of the Head and neck.
- Consequences of C-terminal domains and N-terminal signal peptide deletions on LEKTI secretion, stability, and subcellular distribution.
- Mortality risk from squamous cell skin Cancer.
- Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype.
- Is there a role for selective neck dissection after chemoradiation for head and neck Cancer?
- BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells.
- Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
- SPINK5 and Netherton Syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases.
- Parathyroid carcinoma: a 22-year experience.
- Expression of LEKTI domains 6-9' in the baculovirus expression system: recombinant LEKTI domains 6-9' inhibit trypsin and subtilisin A.
- Parathyroid carcinoma: evaluation and interdisciplinary management.
- Production of serpins using baculovirus expression systems.
- The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human Cancer cells.
- Identification of 9 genes differentially expressed in Head and neck squamous cell carcinoma.
- Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.
- Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous Cancer cells by the t...
- Medullary thyroid Cancer.
- Inhibition of the cysteine proteinases cathepsins K and L by the serpin Headpin (SERPINB13): a kinetic analysis.
- p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
- A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human Oral carcinoma sublines selected from a poorly metast...
- Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis.
- Simultaneous reconstruction of the posterior pharyngeal wall and cervical spine with a free vascularized fibula osteocutaneous flap.
- A prospective study of intraoperative lymphatic mapping for Head and neck cutaneous melanoma.
- Serum squamous cell carcinoma antigen is a useful biologic marker in patients with inverted papillomas of the sinonasal tract.
Schools
Northeastern Oh Univs Coll Of Med
Hennepin County Med Center
University Of Minnesota
MD Anderson Cancer Center
Procedures Preformed
- Continuous Positive Airway Pressure (CPAP)
- Diagnostic Nasal and-or Sinus Endoscopy
- Ear Tube Placement
- Excision of Parotid, Sublingual, or Submandibular Gland
- View All
Conditions Treated
- Allergic Rhinitis
- Bell's Palsy
- Cholesteatoma
- Chronic Sinusitis
- View All
Doctors Specialties
- Ear, Nose, and Throat
- Otolaryngology (ENT)
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Fellow (FAAO-HNS)
- Fellow (FACS)
- Super Doctor
Education
-
University of Minnesota at Fairview -
Hennepin County Medical Center -
Northeast Ohio Medical University
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1902905219 | |
| NPPES Provider LastName | CLAYMAN | |
| NPPES Provider FirstName | GARY | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Otolaryngology | |
| Total Claim Count | 152.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 11.84 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1902905219 |
| Last Name Of The Provider | CLAYMAN |
| First Name Of The Provider | GARY |
| View All |
Similar Doctors
|
Dr. Amber U. Luong, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Herbert J. Ashe Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Horacio J. Guzman, MD |
|
Dr. Bechara Y. Ghorayeb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Walter D. Appling, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Cuthbertson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer Dang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christian A. Corbitt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph A. Malsky, MD
This Doctor is OpenDoctor Recommended.
|